Search Results
Search for other papers by Ioulia Chatzistamou in
Google Scholar
PubMed
Peromyscus Genetic Stock Center, Office of Research, University of South Carolina, Columbia, South Carolina, USA
Department of Biochemistry, University of Athens Medical School, Athens, Greece
Search for other papers by Hippokratis Kiaris in
Google Scholar
PubMed
Estrogen receptor (ER)-positive breast cancers account for about two thirds of total breast cancer cases. Of those, about one half is diagnosed in post-menopausal women ( http://www.breastcancer.org/symptoms/understand_bc/statistics ). Hormone
Search for other papers by Elgene Lim in
Google Scholar
PubMed
Search for other papers by Gerard Tarulli in
Google Scholar
PubMed
Search for other papers by Neil Portman in
Google Scholar
PubMed
Search for other papers by Theresa E Hickey in
Google Scholar
PubMed
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Search for other papers by Carlo Palmieri in
Google Scholar
PubMed
Introduction There are three major sex steroid hormones – estrogen, progesterone and androgen – and each affect the signalling activity of its cognate sex steroid receptor (SSR), that is the estrogen receptor-α (ER), progesterone receptor (PR
Search for other papers by Etienne Leygue in
Google Scholar
PubMed
Search for other papers by Leigh C Murphy in
Google Scholar
PubMed
estrogen is involved in these processes continues to evolve and is more complex and multifaceted than originally thought ( Zwart et al . 2011 ). In particular, one critical discovery has been the identification of a second estrogen receptor (ER), called
Search for other papers by Vanessa W Lim in
Google Scholar
PubMed
Search for other papers by Jun Li in
Google Scholar
PubMed
Search for other papers by Yinhan Gong in
Google Scholar
PubMed
Search for other papers by Aizhen Jin in
Google Scholar
PubMed
Department of Obstetrics and Gynaecology, National Registry of Diseases Office, Division of Cancer Control and Population Sciences, Department of Epidemiology, Duke-NUS Graduate Medical School Singapore, Saw Swee Hock School of Public Health, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, NUHS Tower Block, Level 12, 1E Kent Ridge Road, Singapore 119228, Singapore
Search for other papers by Jian-Min Yuan in
Google Scholar
PubMed
Search for other papers by Eu Leong Yong in
Google Scholar
PubMed
Department of Obstetrics and Gynaecology, National Registry of Diseases Office, Division of Cancer Control and Population Sciences, Department of Epidemiology, Duke-NUS Graduate Medical School Singapore, Saw Swee Hock School of Public Health, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, NUHS Tower Block, Level 12, 1E Kent Ridge Road, Singapore 119228, Singapore
Search for other papers by Woon-Puay Koh in
Google Scholar
PubMed
circulating estrogen levels have been reported between Asian and Caucasian women ( Bernstein et al . 1990 , Shimizu et al . 1990 , Wu & Pike 1995 ). Estrogen receptor α (ERα) and ERβ bioassays are classically used to identify estrogenic compounds present
Search for other papers by L Zeng in
Google Scholar
PubMed
Search for other papers by H A Zielinska in
Google Scholar
PubMed
Search for other papers by A Arshad in
Google Scholar
PubMed
Search for other papers by J P Shield in
Google Scholar
PubMed
Search for other papers by A Bahl in
Google Scholar
PubMed
Search for other papers by J M P Holly in
Google Scholar
PubMed
Search for other papers by C M Perks in
Google Scholar
PubMed
for all subtypes of breast cancer. In a study of women involved in three large trials, inferior disease-free survival and worse overall survival was only identified in women with estrogen receptor (ERα) positive breast cancer and not for other subtypes
Division of Molecular Carcinogenesis, the Netherlands Cancer Institute, Amsterdam, the Netherlands
Search for other papers by Tesa M Severson in
Google Scholar
PubMed
Search for other papers by Wilbert Zwart in
Google Scholar
PubMed
genders and specific gene products. Breast cancer is almost automatically linked with female and estrogen receptor alpha (ERα) action. Although this is intrinsically true, it is by far not the full story, as breast cancer is neither gender-exclusive nor
Search for other papers by Yumi Endo in
Google Scholar
PubMed
Search for other papers by Tatsuya Toyama in
Google Scholar
PubMed
Search for other papers by Satoru Takahashi in
Google Scholar
PubMed
Search for other papers by Nobuyasu Yoshimoto in
Google Scholar
PubMed
Search for other papers by Mai Iwasa in
Google Scholar
PubMed
Search for other papers by Tomoko Asano in
Google Scholar
PubMed
Search for other papers by Yoshitaka Fujii in
Google Scholar
PubMed
Search for other papers by Hiroko Yamashita in
Google Scholar
PubMed
Introduction There are large-scale molecular differences between estrogen receptor α (ERα)-positive and ER-negative breast cancers ( Sorlie et al . 2003 ). ER is essential for estrogen-dependent growth, and its level of expression is a crucial
Search for other papers by Srilatha Swami in
Google Scholar
PubMed
Search for other papers by Aruna V Krishnan in
Google Scholar
PubMed
Search for other papers by Lihong Peng in
Google Scholar
PubMed
Search for other papers by Johan Lundqvist in
Google Scholar
PubMed
Search for other papers by David Feldman in
Google Scholar
PubMed
Introduction Breast cancer (BCa) is the most common cancer in women in the USA ( Siegel et al . 2012 ). Estrogens drive the proliferation of mammary epithelial cells and therefore promote the growth of estrogen receptor-positive (ER+) BCa cells
Search for other papers by Tobias Zellweger in
Google Scholar
PubMed
Search for other papers by Susanne Stürm in
Google Scholar
PubMed
Search for other papers by Silvia Rey in
Google Scholar
PubMed
Search for other papers by Inti Zlobec in
Google Scholar
PubMed
Search for other papers by Joel R Gsponer in
Google Scholar
PubMed
Department of Urology, Institute for Pathology, Institute of Pathology, Department of Urology, St Claraspital, Basel, Switzerland
Search for other papers by Cyrill A Rentsch in
Google Scholar
PubMed
Search for other papers by Luigi M Terracciano in
Google Scholar
PubMed
Search for other papers by Alexander Bachmann in
Google Scholar
PubMed
Search for other papers by Lukas Bubendorf in
Google Scholar
PubMed
Search for other papers by Christian Ruiz in
Google Scholar
PubMed
the role of the AR and the two estrogen receptors ERα and ERβ in the context of PC progression, we performed a comprehensive analysis of their expression (AR, ERα and ERβ), phosphorylation (pAR 210 ) and genomic amplification status ( AR ) in a cohort
Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Deeley Research Centre, Faculty of Medicine
Search for other papers by Leigh C Murphy in
Google Scholar
PubMed
Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Deeley Research Centre, Faculty of Medicine
Search for other papers by Srinivas V Seekallu in
Google Scholar
PubMed
Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Deeley Research Centre, Faculty of Medicine
Search for other papers by Peter H Watson in
Google Scholar
PubMed
Introduction Targeting the estrogen receptor (ER) signaling pathway using the selective ER modulator (SERM), tamoxifen, is efficacious in both treating and preventing breast cancer ( Jensen & Jordan 2003 , Jordan 2003 ). Owing to the central role